The caspase activation plays a critical role in programmed cell death (apoptosis), inflammation, and other cellular processes. This essential pathway ensures the removal of damaged or unnecessary cells, maintaining cellular homeostasis. Disruptions in caspase activity can lead to various diseases, including cancer, autoimmune disorders, and neurodegenerative conditions.
AnyGenes, with its innovative range of products, including specialized caspase assays and SignArrays® kits support research in this field by offering precise tools to study caspase activity and its regulation, helping scientists explore these critical pathways and their implication in health and disease.
A schematic representation depicting the molecular pathways with the biomarkers of caspase-dependent programmed cell death: intrinsic and extrinsic pathways.
Caspases (Cysteine-aspartic proteases) are a family of protease enzymes that are essential for initiating and executing apoptosis. They exist as inactive proenzyme and are activated in response to specific cellular signals.
Caspases are broadly classified into two types based on their function:
Once caspases are activated, they begin a cascade that dismantles the cell: DNA fragmentation, degradation of cellular protein, membrane blebbing, cell shrinkage and phagocytosis.
Caspace activation occurs through two primary pathways:
Aberrant caspase activation or inhibition has been implicated in several diseases:
Ongoing research is exploring how manipulating activation of caspases can offer new therapeutic approaches. Caspase inhibitors, for instance, are being developed as potential treatments for neurodegenerative disorders, while activators of caspases are being investigated as anti-cancer therapies
Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file
and send it at
contact@anygenes.com
to get started on your project.